Myelodysplastic syndrome (MDS) after acute promyelocytic leukemia (APL): The European APL Group experience.

被引：0
|
作者：
Lobe, J
Rigal-Huguet, F
Vekhoff, A
Desablens, B
Bordessoule, D
Mounier, C
Ferrant, A
Sanz, M
Fey, M
Chomienne, C
Degos, L
Fenaux, P
机构：
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1295
引用
收藏
页码：334A / 334A
页数：1
相关论文
共 50 条
  • [31] Acute Promyelocytic Leukemia: High Risk and Relapsed APL
    Lengfelder, E.
    Hecht, A.
    Nowak, D.
    Nolte, F.
    Hofmann, W. -K.
    ANNALS OF HEMATOLOGY, 2015, 94 : S34 - S35
  • [32] Acute promyelocytic leukemia (APL) in pregnancy: A systematic review
    Manandhar, Samyak
    Verma, Vivek
    Giri, Smith
    Pathak, Ranjan
    Bhatt, Vijaya Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
    C Callens
    S Chevret
    J-M Cayuela
    B Cassinat
    E Raffoux
    S de Botton
    X Thomas
    A Guerci
    N Fegueux
    A Pigneux
    A-M Stoppa
    T Lamy
    F Rigal-Huguet
    A Vekhoff
    S Meyer-Monard
    A Ferrand
    M Sanz
    C Chomienne
    P Fenaux
    H Dombret
    Leukemia, 2005, 19 : 1153 - 1160
  • [34] Outcome of acute promyelocytic leukemia (APL) treated with all trans retinoic acid (ATRA) and chemotherapy (CT) in elderly patients (>60 years):: The European Group experience.
    Ades, L
    Chevret, S
    de Botton, S
    Thomas, X
    Dombret, H
    Sanz, M
    Guerci, A
    San Miguel, J
    De La Serna, J
    Garo, C
    Stoppa, AM
    Reman, O
    Stamatoullas, A
    Gardin, C
    Fey, M
    Cahn, JY
    Sotto, JJ
    Bourhis, JH
    Parry, A
    Chomienne, C
    Degos, L
    Fenaux, P
    BLOOD, 2003, 102 (11) : 619A - 619A
  • [35] Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL):: a retrospective study from the European APL Group
    Callens, C
    Chevret, S
    Cayuela, JM
    Cassinat, B
    Raffoux, E
    de Botton, S
    Thomas, X
    Guerci, A
    Fegueux, N
    Pigneux, A
    Stoppa, AM
    Lamy, T
    Rigal-Huguet, F
    Vekhoff, A
    Meyer-Monard, S
    Ferrand, A
    Sanz, M
    Chomienne, C
    Fenaux, P
    Dombret, H
    LEUKEMIA, 2005, 19 (07) : 1153 - 1160
  • [36] Diagnostic value of immunophenotyping in acute promyelocytic leukemia (APL).
    Kakkas, I
    Pagoni, M
    Baltathakis, I
    Garofalaki, M
    Psarra, A
    Kapsimali, V
    Tzotziou, I
    Poulopoulou, Z
    Nikiforakis, E
    Papasteriades, C
    BLOOD, 2001, 98 (11) : 201B - 201B
  • [37] CHROMOSOME-ABNORMALITIES IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    VANDENBERGHE, H
    LOUWAGIE, A
    BROECKAERTVANORSHOVEN, A
    DAVID, G
    VERWILGHEN, R
    MICHAUX, JL
    SOKAL, G
    CANCER, 1979, 43 (02) : 558 - 562
  • [38] Acute Promyelocytic Leukemia: High Risk and Relapsed APL
    Lengfelder, E.
    Hecht, A.
    Nowak, D.
    Nolte, F.
    Hofmann, W. -K.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 34 - 35
  • [39] BLEEDING IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIBRINOLYSIS OR DEFIBRINATION
    KRSNIK, I
    ESCRIBA, A
    LOPEZRUBIO, M
    ALARCON, C
    DELPOTRO, E
    DIAZMEDIAVILLA, J
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (01): : 39 - 41
  • [40] Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
    Ghiaur, Alexandra
    Ghiaur, Gabriel
    HAEMATOLOGICA, 2023, 108 (11) : 2886 - 2888
12345